THE

—The gp120 vaccine developed by Hoffmann-La Roche’s Genentech unit finally receives full approval from the FDA. In clinical trials conducted by the World Health Organization in Thailand and Canada, the vaccine has been proven 96 percent effective at preventing HIV infection. ................
................